MEN 2 is a rare genetic condition that causes tumors to grow in the thyroid, parathyroid and adrenal glands, lips, mouth, eyes and digestive tract
Available in store and online.
A separate KFF analysis from March about Medicare Part D spending data from the Centers for Medicare & Medicaid Services found that gross Medicare spending on the three newest versions of GLP-1 diabetes medicines (Ozempic, Rybelsus and Mounjaro) that also have been approved for weight loss skyrocketed from $57 million in 2018 to $5.7 billion in 2022
McPherson S, Hardy T, Henderson E, et al
Newer pills for weight loss, as well as injections from Novo and Lilly, are available through the drugmakers' own websites at discounted prices, driven by a deal with the Trump administration for its site TrumpRx.gov